To the full analysis
Buyback calculator for OPKO Health
OPKO Health stock: key metrics
OPKOPKO Health had an operating margin of −36.1% and a return on invested capital (ROIC) of −12.5% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2006 | no data | no data | no data |
| 2007 | 4.6% | −31,624.4% | −31,688.9% |
| 2008 | 9.3% | −393.7% | −422.0% |
| 2009 | 27.2% | −173.6% | −229.0% |
| 2010 | 52.6% | −39.1% | no data |
| 2011 | 38.4% | −82.9% | no data |
| 2012 | 40.7% | −79.2% | −61.7% |
| 2013 | 49.4% | −82.5% | −118.5% |
| 2014 | 47.3% | −160.1% | −188.4% |
| 2015 | 52.2% | −20.0% | −6.1% |
| 2016 | 49.9% | −6.0% | −4.0% |
| 2017 | 35.8% | −28.6% | −31.6% |
| 2018 | 38.9% | −17.3% | −15.5% |
| 2019 | 36.5% | −30.4% | −34.9% |
| 2020 | 37.7% | 4.0% | 2.1% |
| 2021 | 32.8% | 1.1% | −1.7% |
| 2022 | 28.7% | −22.5% | −32.7% |
| 2023 | 36.8% | −18.2% | −21.9% |
| 2024 | 43.6% | −21.3% | −7.5% |
| 2025 | 21.1% | −36.1% | −37.2% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2006 | −8.0% | −10.9% | −7.4% |
| 2007 | −100.0% | no data | −100.0% |
| 2008 | −100.0% | no data | −100.0% |
| 2009 | −52.2% | −89.3% | −34.4% |
| 2010 | no data | −32.3% | no data |
| 2011 | no data | −31.1% | no data |
| 2012 | −14.3% | −19.8% | −10.0% |
| 2013 | −13.1% | −11.3% | −8.2% |
| 2014 | −20.5% | −13.0% | −13.5% |
| 2015 | −1.5% | −5.6% | −1.1% |
| 2016 | −2.3% | −2.9% | −1.7% |
| 2017 | −16.6% | −11.1% | −11.8% |
| 2018 | −8.5% | −7.4% | −6.2% |
| 2019 | −19.5% | −12.1% | −13.6% |
| 2020 | 1.8% | 2.0% | 1.2% |
| 2021 | −1.8% | 0.8% | −1.3% |
| 2022 | −21.0% | −10.2% | −15.2% |
| 2023 | −13.6% | −7.4% | −9.4% |
| 2024 | −3.9% | −7.9% | −2.4% |
| 2025 | −17.8% | −12.5% | −11.7% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 31 Jan 2022)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.